Analysis of the Economic Burden of Chronic Kidney Disease With Comorbidities Among Patients in Xuzhou, China

To analyze the costs and medication patterns of patients with chronic kidney disease (CKD) and comorbidities in Xuzhou, China, using a large electronic medical records database. Data were obtained from an electronic medical records database. The annual per-person and per-visit cost of hospitalizatio...

Full description

Saved in:
Bibliographic Details
Published in:International journal of public health 2024-07, Vol.69, p.1607000
Main Authors: Jie, Wan, Yao, Minghong, Wang, Mingqi, Wang, Yuning, Jia, Yulong, Liu, Yanmei, Zou, Kang, Sun, Xin
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
China - epidemiology
chronic kidney disease
Comorbidity
composition of expenses
Cost of Illness
economic burden
Female
Health Care Costs - statistics & numerical data
Hospitalization - economics
Hospitalization - statistics & numerical data
Humans
Male
medication patterns
Middle Aged
Public Health Archive
Renal Insufficiency, Chronic - economics
Renal Insufficiency, Chronic - epidemiology
Young Adult
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To analyze the costs and medication patterns of patients with chronic kidney disease (CKD) and comorbidities in Xuzhou, China, using a large electronic medical records database. Data were obtained from an electronic medical records database. The annual per-person and per-visit cost of hospitalization, as well as the proportions of those costs, are presented. The majority of the participants were middle-aged men, and had medical insurance. Glomerulonephritis was the primary cause of CKD in patients with an identified etiology. The average per-visit cost of hospitalization for the CKD-renal anemia and CKD-mineral and bone disorder groups was 8,674.5 (5,154.3-13,949.6) and 8,182.6 (4,798.2-12,844.7) Yuan, respectively, which was greater than that of the other groups. The major expenses incurred were for diagnostics, drug usage, surgical procedures, laboratory tests and material costs. The substantial burden imposed by CKD with comorbidities indicates the importance of implementing public health strategies aimed at detecting and preventing these conditions in the general population. With the aging population, our nation may experience a greater CKD-related economic burden.
ISSN:1661-8564
1661-8556
1661-8564
DOI:10.3389/ijph.2024.1607000